Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Therapeutic Use in Pediatric Populations Clinical trials in children with idiopathic growth hormone deficiency showed therapeutic efficacy: Daily subcutaneous sermorelin 30 mcg/kg at bedtime significantly increased height velocity in prepubertal children Sustained growth acceleration maintained through 12-36 months of treatment in published studies Catch-up growth achieved in approximately 74% of treated children in 6-month trials Greatest responses observed in children with delayed bone age and lower baseline growth rates However, sermorelin required higher doses than initially anticipated and demonstrated lower potency compared to recombinant growth hormone, leading to commercial discontinuation despite proven safety
2.5.6 Measurement of IMA Levels Serum IMA levels were measured spectrophotometrically based on the principle of albumins cobalt-binding capacity, as described by Bar-Or et al
The numbers below describe commonly reported compounded practice , not a recommendation
Seek same-day urgent care for sudden vision loss, numerous new floaters, flashes of light, a curtain or shadow across your visual field, or distorted vision where straight lines appear wavy
US$ 24.01
US$ 23.38
US$ 28.01
US$ 26.74
US$ 29.62
US$ 28.26
US$ 20.65
US$ 25.97
US$ 24.58
US$ 24.80
